No end in sight for telomerase-targeted cancer drugs

Nat Med. 2013 Jan;19(1):6. doi: 10.1038/nm0113-6.
No abstract available

Publication types

  • News

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Clinical Trials as Topic
  • Humans
  • Indoles / pharmacology
  • Indoles / therapeutic use
  • Molecular Targeted Therapy
  • Neoplasms / drug therapy*
  • Neoplasms / enzymology
  • Niacinamide / analogs & derivatives
  • Niacinamide / pharmacology
  • Niacinamide / therapeutic use
  • Oligonucleotides
  • Peptide Fragments / pharmacology
  • Peptide Fragments / therapeutic use
  • Telomerase / antagonists & inhibitors*
  • Telomerase / metabolism
  • Telomerase / pharmacology
  • Telomerase / therapeutic use
  • Thrombocytosis / drug therapy

Substances

  • Antineoplastic Agents
  • Indoles
  • Oligonucleotides
  • Peptide Fragments
  • Niacinamide
  • GV1001 peptide
  • Telomerase
  • imetelstat